Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

14.43
Delayed Data
As of 3:59pm ET
 +0.64 / +4.64%
Today’s Change
6.50
Today|||52-Week Range
29.24
-10.98%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Gad Thomas
Director
Sale1/20/2022112,767$11.33$1.3M+31.03%
Gad Thomas
Director
Sale2/08/2022125,863$7.01$882.3K+108.09%
Gad Thomas
Director
Sale11/23/202150,000$17.06$853.0K-16.47%
Gad Thomas
Director
Sale2/04/2022101,104$7.70$778.5K+87.01%
Gad Thomas
Director
Sale1/19/202269,414$10.89$755.9K+35.85%
Gad Thomas
Director
Sale2/07/202291,031$7.59$690.9K+92.26%
Gad Thomas
Director
Sale12/06/202140,000$16.48$659.2K-12.89%
Gad Thomas
Director
Sale1/24/202255,783$10.96$611.4K+31.03%
Gad Thomas
Director
Sale1/21/202250,134$10.51$526.9K+40.90%
Gad Thomas
Director
Sale2/09/202264,276$6.96$447.4K+104.84%
Page of 4